27.12.2012 Views

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

were older than 65 y) which can be compared to <strong>the</strong> natural incidence<br />

<strong>of</strong> fatal cancer in our population. Conclusion. Previous researches<br />

revealed that <strong>the</strong> risk <strong>of</strong> radiation induced cancer is much smaller than<br />

<strong>the</strong> natural risk <strong>of</strong> cancer. Our results showed that increased numbers<br />

<strong>of</strong> CT screening procedures has not been correlated with increased incidence<br />

<strong>of</strong> secondary malignancies. Age was only predictive risk indicator<br />

(p15 fold rise in <strong>the</strong> titers <strong>of</strong> IgG against HHV6 were detected<br />

indicating reactivation <strong>of</strong> latent infection. Moreover, presence <strong>of</strong><br />

effector CD8 + CD7 - CD57 + T cells subset also indicate an acute immune<br />

response to viral infection and chronic antigenic stimulation maybe due<br />

to inability to suppress HHV6 reactivation. These findings could indicate<br />

impaired function and expansion <strong>of</strong> CD7 + CD8 + memory T cells<br />

during Dasatinib treatment. Interestingly, when treatment with Dasatinib<br />

was stopped, <strong>the</strong> immunosupression reverted, and <strong>the</strong> immune<br />

system was able to clear <strong>the</strong> virus without need for specific treatment<br />

(Foscarnet or Ganciclovir). Dasatinib was reinitiated at a lower dose 1<br />

month after discontinuation <strong>of</strong> <strong>the</strong> medication. Repeated analysis<br />

demonstrated a decrease in <strong>the</strong> titers <strong>of</strong> IgG antibodies against herpes<br />

6 virus. Conclusions. <strong>the</strong>se clinical features reflect <strong>the</strong> need <strong>of</strong> memory<br />

T cells surveillance to control chronic latent infections. Patients treated<br />

with Dasatinib may develop reactivation <strong>of</strong> viral infections and require<br />

greater surveillance to detect infectious complications. Tyrosine kinase<br />

inhibitors dose modification could be sufficient to prevent immunosupression<br />

in some patients.<br />

1372<br />

CORD BLOOD LYMPHOCYTE SUBTYPES IN TERM INFANTS<br />

A. Roumiantsev, 1 E. Boyakova, 1 A. Schutieva, 1 S. Sabirova, 2<br />

E. Podkolzina, 2 E. Karpova, 2 E. Spiridonova, 2 J. Rouminatseva, 1<br />

O. Mayorova2 1 Research Center <strong>of</strong> Pediatric <strong>Hematology</strong>, MOSCOW; 2 Stem Cell Bank,<br />

MOSCOW, Russian Federation<br />

Background. Standards <strong>of</strong> public cord blood banking include volume<br />

reduction <strong>of</strong> samples/ Investigation <strong>of</strong> cord blood specific features is<br />

necessary for quality control and establishing new methods. Aim. Study<br />

<strong>of</strong> immunological parameters <strong>of</strong> cord blood lymphocytes and influence<br />

<strong>of</strong> cord blood volume reduction on number <strong>of</strong> lymphocyte subtypes.<br />

Materials and methods. We evaluated cord blood samples from 30 term<br />

newborns (37-42 weeks <strong>of</strong> gestation). Samples were collected from cord<br />

vein using closed system, containing 35 ml <strong>of</strong> CPDA, 5-15 minute after<br />

delivery. Lymphocyte subtypes were analyzed using flow cytometry<br />

before and after volume reduction according to <strong>the</strong> New York cord<br />

blood bank protocol. We found no differences in number <strong>of</strong> CD3 + lymphocytes<br />

before and after volume reduction, and it was 17,9±1,44% and<br />

19,2±1,4% from total nucleated cells, respectively. Number and ratio <strong>of</strong><br />

CD3 + CD4 + cells and CD3 + CD8 + cells after volume reduction has also not<br />

changed and was: before volume reduction CD3+CD4+ cells-<br />

12,62±1,12%, CD3 + CD8 + cells-5,62±0,53%; after volume reduction<br />

CD3 + CD4 + cells-13,23±1,12%, CD3 + CD8 + cells-5,52±0,48% from total<br />

nucleated cells. Number <strong>of</strong> natural killer cells (NK) - CD16 + CD56 + cellsin<br />

native cord blood nucleated cells was 5,97±0,67% and significantly<br />

raised after volume reduction-8,54±0,91% (p = 0,027). Number <strong>of</strong><br />

CD33 + CD13 + cells was 12,5±0,76% and it significantly increased<br />

15,82±0,81% (p =0,005) after extraction. This is may be related to<br />

greater granulocyte shedding (lost?) during volume reduction. Number<br />

<strong>of</strong> active lymphocytes has not changed and was 0,40±0,08% before<br />

and 0,38±0,09% after volume reduction. Number <strong>of</strong> CD14 + cells has not<br />

raised and was 8,65±1,58% before and 9,11±1,76% after volume reduction.<br />

We found a tendency to decreased CD15 + cells number after volume<br />

reduction. This may be result <strong>of</strong> greater lost <strong>of</strong> this type <strong>of</strong> cells in<br />

comparison with o<strong>the</strong>r leukocyte subtypes during volume reduction n.<br />

Its number was 39,32±3,45% before and 35,23±3,26% after volume<br />

reduction. Conclusion. We evaluated and characterized cord blood lymphocyte<br />

subtypes and found no influence <strong>of</strong> cord blood concentration<br />

method on CD3 + lymphocytes count. Number <strong>of</strong> NK-cells and<br />

CD33 + CD13 + cells has significantly increased after procedure <strong>of</strong> volume<br />

reduction.<br />

haematologica/<strong>the</strong> hematology journal | 2007; 92(s1) | 493

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!